# Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

> **NCT00646984** · PHASE4 · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 147 (actual)

## Conditions studied

- HIV-Associated Lipodystrophy Syndrome

## Interventions

- **DRUG:** Standard continuous antiretroviral therapy
- **DRUG:** CD-4 guided therapy interruption
- **DRUG:** Viral load driven treatment interruption

## Key facts

- **NCT ID:** NCT00646984
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2005-04
- **Final completion:** 2006-04
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2008-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646984, "Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00646984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
